UPDATE 1-Merck to pay $5.9 mln for misleading marketing of pink eye drug: U.S.
June 17, 2015 at 18:06 PM EDT
NEW YORK, June 17 (Reuters) - Merck & Co Inc has agreed to pay $5.9 million to resolve claims that a former unit fraudulently promoted a drug used to treat pink eye for unapproved purposes, U.S. authorities announced on Wednesday.